ADGRB1 and Parkinson disease: Overexpression of ADGRB1 resulted in decreased levels of nuclear condensations associated with cell death and Parkinson's disease, suggesting that ADGRB1 can prohibit cell death in the neurodegenerative pathway (a potential therapeutic target) of Parkinson’s disease (Choi et al., 2018).